Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
T.GUD
Alternate Symbol(s):
KHTRF
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jul 26, 2023 8:24pm
RE:Healthcare & Biotech stressed on cnbc w panelists
Gold investor is dreaming in red while he/she counts the losses market making all time high again and GUD ..........hm...hmmm
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Jul 25, 2023 3:19pm
Healthcare & Biotech stressed on cnbc w panelists
Obesity , cancer, other ailments being discussed & ageing poplulations driving a growth engine for sector - elective procedures a real cost driver near term passed on to consumers - pharma
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Jul 20, 2023 3:59pm
pharma & healthcare to be next area of market focus on cnbc
being discussed this afternoon
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jul 18, 2023 9:32am
RE:Endo ditches auction ...
Everything that Mr. Micky Bugsy Mugsy invest in turns red. Anyone surprised? Nop...
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Jul 17, 2023 11:54pm
Endo ditches auction ...
Looks like Endo is ditching the auction - can't get any bidders to bid. Therefore, looks like they are giving the company over to creditors. What will creditors do with the business ? Sell
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on Jul 17, 2023 12:43pm
Text book to lose fortune
Kind of odd, Mr Micky Bugsy Mugsy does not understand the difference of what type investment text books should be read to make a living, If I may suggest stay away from color red tex books
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Jul 13, 2023 10:35pm
Not worried ...
I've got no issues with the way this company is developing. I'm used to this. This is textbook my friend !!!! Simply textbook !!!
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jul 13, 2023 7:27am
RE:RE:New Press Release - Knight Announces Normal Course Issuer Bid
.........and they are all losing fortunes ............after ten years and ...yes it is getting very tigheter on their pockets/portafolio and exspecially mighty mickey Mugsy
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Comment by
EbbFlow88
on Jul 12, 2023 9:58am
RE:New Press Release - Knight Announces Normal Course Issuer Bid
Public float of GUD is 60M shares. 44% of the company is owned by 3 people/groups. It's getting tighter
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jul 12, 2023 7:30am
New Press Release - Knight Announces Normal Course Issuer Bid
MONTREAL, July 12, 2023 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "Company "), a leading pan-American (ex-US) specialty pharmaceutical company, announced today acceptance by the Toronto Stock Exchange (the "TSX") of the Company's Notice of Intention to Make a Normal...
read article.
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on Jul 11, 2023 7:16pm
let's do some math so we can help mugsy
Mugsy claims to have accumulate GUD shares for the past 10 years or so. Let's be kind and assume that mugsy GUD avarage cost is $7. Ha...let's say that the avarage inflation rate is 3
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on Jul 10, 2023 7:12pm
Mugsy et all
One sep forward two backwords investor mugsy and aliases will never understand that the buy back has not worked and will not work for GUD shareholders. But for mugsy it does not matter he/she/the has
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jul 06, 2023 6:20pm
RE:June buybacks
Yes - looking forward to when we're below 100 MM in share count. That's one benefit of the price staying down here - GUD willing to keep going with the buybacks.
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Post by
EbbFlow88
on Jul 05, 2023 9:15am
June buybacks
We should be below 107M shares now with another 776,700 shares cancelled. NCIB should also be renewed next week.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >